Tetanus immunoglobulin human 250unit solution for injection vials
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Tetanus immunoglobulin human
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Part of the Liberim brand family (generic: Tetanus immunoglobulin human)
MHRA licensed products
View all licensed products for Tetanus immunoglobulin human on the MHRA register
Tetanus immunoglobulin human 250unit solution for injection vials
Liberim T 250unit solution for injection vials
Scottish National Blood Transfusion Service
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 17 · Randomised trials: 7 · 1982–2026
Showing the 50 most relevant studies, sorted by most relevant.
Ayouni I, Mbangiwa T, Amponsah-Dacosta E, et al.
2024
- Whooping Cough
- Tetanus
- Developing Countries
Esmaeili Z, Kamal Shahsavar S, Ghazvini K
2025
D. Miranda-Filho, R. Ximenes, A. A. Barone, et al.
BMJ : British Medical Journal, 2004
G. Armah, Kristen D. C. Lewis, M. Cortese, et al.
The Journal of Infectious Diseases, 2016
Zi-jing Liang, Si Liu, Wei Guo, et al.
Nature Medicine, 2025
- Tetanus
- Tetanus Antitoxin
- Antibodies, Monoclonal
X. Liu, C. Wang, Z. Liang, et al.
Annals of Emergency Medicine, 2024
Xie Z, Yuan L, Qiao Y, et al.
2025
C. Rodrigo, Deepika Fernando, S. Rajapakse
Critical Care, 2014
B. DeKosky, G. Ippolito, Ryan P Deschner, et al.
Nature Biotechnology, 2013
H. T. Loan, L. Yen, E. Kestelyn, et al.
The American Journal of Tropical Medicine and Hygiene, 2018
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.